The impact of CBP expression in estrogen receptor-positive breast cancer

被引：0
|
作者：
Wafaa S. Ramadan
Iman M. Talaat
Mahmood Y. Hachim
Annette Lischka
Timo Gemoll
Raafat El-Awady
机构：
[1] University of Sharjah,Sharjah Institute for Medical Research
[2] University of Sharjah,College of Medicine
[3] University of Alexandria,Department of Pathology, Faculty of Medicine
[4] Mohammed Bin Rashid University of Medicine and Health Sciences,College of Medicine
[5] University of Lübeck and University Hospital Schleswig-Holstein,Section for Translational Surgical Oncology and Biobanking, Department of Surgery
[6] University of Sharjah,College of Pharmacy
来源：
Clinical Epigenetics | 2021年 / 13卷
关键词：
Breast cancer; CBP; GCN5; ERα; HER2; Luminal subtypes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The impact of CBP expression in estrogen receptor-positive breast cancer
    Ramadan, Wafaa S.
    Talaat, Iman M.
    Hachim, Mahmood Y.
    Lischka, Annette
    Gemoll, Timo
    El-Awady, Raafat
    [J]. CLINICAL EPIGENETICS, 2021, 13 (01)
  • [2] Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer
    Agrawal, Anil
    Ziolkowski, Piotr
    Grzebieniak, Zygmunt
    Jelen, Michal
    Bobinski, Piotr
    Agrawal, Siddarth
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (08) : 550 - 555
  • [3] Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer
    Tokunaga, Eriko
    Hisamatsu, Yuichi
    Taketani, Kenji
    Yamashita, Nami
    Akiyoshi, Sayuri
    Okada, Satoko
    Tanaka, Kimihiro
    Saeki, Hiroshi
    Oki, Eiji
    Aishima, Shinichi
    Oda, Yoshinao
    Morita, Masaru
    Maehara, Yoshihiko
    [J]. CANCER MEDICINE, 2013, 2 (06): : 763 - 773
  • [4] Major Impact of Sampling Methodology on Gene Expression in Estrogen Receptor-Positive Breast Cancer
    Gao, Qiong
    Lopez-Knowles, Elena
    Cheang, Maggie Chon U.
    Morden, James
    Ribas, Ricardo
    Sidhu, Kally
    Evans, David
    Martins, Vera
    Dodson, Andrew
    Skene, Anthony
    Holcombe, Chris
    Mallon, Elizabeth
    Evans, Abigail
    Bliss, Judith M.
    Robertson, John
    Smith, Ian
    Martin, Lesley-Ann
    Dowsett, Mitch
    [J]. JNCI CANCER SPECTRUM, 2018, 2 (02)
  • [5] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [6] New Strategies in Estrogen Receptor-Positive Breast Cancer
    Johnston, Stephen R. D.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (07) : 1979 - 1987
  • [7] Geographic excess of estrogen receptor-positive breast cancer
    Benz, CC
    Clarke, CA
    Moore, DH
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1523 - 1527
  • [8] Estrogen receptor-positive breast cancer: a multidisciplinary challenge
    Zwart, Wilbert
    Theodorou, Vasiliki
    Carroll, Jason S.
    [J]. WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2011, 3 (02) : 216 - 230
  • [9] Risk factors for estrogen receptor-positive breast cancer
    Hwang, ES
    Chew, T
    Shiboski, S
    Farren, G
    Benz, CC
    Wrensch, M
    [J]. ARCHIVES OF SURGERY, 2005, 140 (01) : 58 - 62
  • [10] Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
    Zhang, Xiang H. -F.
    Giuliano, Mario
    Trivedi, Meghana V.
    Schiff, Rachel
    Osborne, C. Kent
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (23) : 6389 - 6397
12345